References
- Madhok R, Mackenzie A, Lee F D. Small bowel ulceration in patients receiving non-steroidal antiinflammatory drugs for rheumatoid arthritis. Q J Med 1986; 255: 53–8
- Jenkins R T, Rooney P J, Jones D B, Bienenstock J, Goodacre R L. Increased intestinal permeability in patients with rheumatoid arthritis: a side effect of oral nonsteroidal antiinflammatory drug therapy. Br J Rheumatol 1987; 26: 103–7
- Aabakken L, Dybdahl J H, Eidsaunet W, Haaland A, Larsen S, Osnes M. Optimal assessment of gastrointestinal side effects induced by non-steroidal anti-inflammatory drugs: endoscopic lesions, faecal blood loss and symptoms not necessarily correlated. Scand J Gastroenterol 1989; 24: 1007–13
- Ollagnier M, Deconsus H, Cherrah Y, Levi F, Mechkouri M, Queneau P. Circadian changes in the pharmacokinetics of oral ketoprofen. Clin Pharmacokinet 1987; 12: 367–78
- Larsen S, Osnes M. The unstimulated duodenal pressure activity in healthy humans. Scand J Gastroenterol 1987; 22(suppl. 131)1–35
- Larsen S, Aabakken L, Lillevold P E, Osnes M. Assessing soft data in clinical trials. Pharmaceut Med 1991; 5: 29–36
- Kendall M, Stuart A. The advanced theory of statistics; vol II & III. Charles Griffin & Co. Ltd., London 1979
- Montgomery D C. Design and analysis of experiments. John Wiley & Sons, New York 1984
- Pocock S J. Clinical Trials; a practical approach. John Wiley & Sons, New York 1985
- Aabakken L, Bjørnbeth B A, Hofstad B, Olaussen B, Larsen S, Osnes M. Comparison of the gastrointestinal side effects of Naproxen formulated as plain tablets, enteric coated tablets or enteric coated granules in capsules. Scand J Gastroenterol 1989; 24(suppl. 163)63–73
- Lehmacher W. Analysis of the crossover design in the presence of residual effects. Statistics in Med 1991; 10: 891–9
- Loet X LE. Safety of Ketoprofen in the elderly: a prospective study on 20000 patients. Scand J Rheumatol 1989, suppl. 83: 21–7
- Schmitt M, Guentert T W. Effect of age on the pharmacokinetics of tenoxicam in comparison to other nonsteroidal anti-inflammatory drugs (NSAIDs). Scand J Rheumatol 1989, suppl. 80: 86–9
- Bitar N. Chronotherapeutic study of ketoprofen slow release on osteoarthrosis. Clin Exp Rheumatol 1987; 5(Suppl. 2)129–36
- Deconsus H, Perpoint B, Boissier C, Ollagnier M, Mismetti P, Hocquart J, et al. A chronotherapeutic trial of ketoprofen in osteoarthrosis. Therapie 1990; 65: 49–55
- Boissier C, Deconsus H, Perpoint B, Ollagnier M, Mismetti P, Hocquart J, et al. Timing optimizes sustained-release ketoprofen treatment of osteoarthrosis. Annu Rev Chronopharmacol 1990; 7: 289–92
- Rachid A. Double-blind, crossover chronotherapeutic trial of sustained-release ketoprofen in treatment of hip osteoarthritis. Arq Bras Med 1988; 62: 309–12
- Venugopal S, Chatterjee S S, Admani A K, Prasad R K, Sayeed A, Husain-Qureshi S, et al. Preliminary results of a multicentre, open, randomized crossover study comparing AM and PM dosing with controlled release ketoprofen in OA, (to be published)
- Lovell D J, Giannini E H, Brewer E J. Time course of response to nonsteroidal antiinflammatory drugs in juvenile rheumatoid arthritis. Arthritis Rheum 1984; 27: 1433–7
- Trondstad R I, Aadland E, Holler T, Olaussen B. Gas-troscopic findings after treatment with enteric-coated and plain Naproxen tablets in healthy subjects. Scand J Gastroenterol 1985; 20: 239–42